王次男。(1990)。寄生澳洲胡桃之三種靈芝及其防治。台灣糖業研究所研究彙報，129：1-10。
王伯徹。(2000)。具開發潛力食藥用菇介紹。食品工業，32：1-16。石信德，陳錦桐、陳啟楨。(2011)。液態菌種於菇類產業之應用。菇類產業發展研討會專刊，37-45。台中。
行政院衛生福利部。(2014)。102 年主要死因死亡率。http://www.doh.gov.tw，資料於 2014 年 8 月 10 日下載。
余艾凌。(2013)。液態發酵靈芝所產胞外多醣產量及其免疫活性探討。國立臺灣海洋大學食品科學系研究所論文。基隆。台灣。
林榮耀。(1996)。靈芝及菇類等真菌類免疫調節蛋白質之研究及探討其臨床應用性。生命科學簡訊，10：2-5。徐慧雯。(2012)。醣類代謝與臨床常見疾病。臨床生物化學，2：29-36。
徐慧雯。(2012)。脂質與臨床常見疾病。臨床生物化學，3：56-58。
陳啟楨。(2002)。食藥用菇菌類大公開-百菇宴 (上)。元氣齋出版社。
陳彥泓。(2015)。靈芝液態發酵液對於原發性高血壓大鼠之降血壓活性評估。國立臺灣海洋大學，食品科學系碩士論文。基隆。台灣。黃展偉、黃國晉、楊偉勛。(2010)。2010 年美國糖尿病學會臨床治療指引摘要。家庭醫學與基層醫療，25：298-303。黃雪芳、劉柯俊、管育慧、董光世、蘇慶華、董大成。(1989)。口服靈芝菌絲培養液之抗癌人工轉移作用。中華癌醫會誌，5：10-15。
詹宏偉。(2003)。不同培養方式對靈芝菌絲體生理活性成分生成之影響。東海大學化公所碩士論文。台中。台灣。璩慶華。(2003)。靈芝之分類學及生理活性物質。北醫學報，20：1-16。
Adaskaveg, J. E. and Gilbertson, R. L. (1986). Cultural studies and genetics of sexuality of Ganoderma lucidum and G. tsugae in relation to the taxonomy of the G. lucidum complex. Mycologia, 78: 694-705.
Adaskaveg, J. E. and Gilbertson, R. L. (1987). Infection and colonization of grapevines by G. lucidum. Plant Disease, 71: 251-253.
Ahmad, F., Ahmad, P. M., Dickstein, R. and Greenfield, E. D. (1981). Detection of ligand-induced perturbations affecting the biotinyl group of mammalian acetyl-coenzyme A carboxylase by using biotin binding antibodies. Biochemical Journal, 197: 95-104.
Allain, C. C., Poon, L. S., Chan, C. S., Richmond, W. and Fu, P. C. (1974). Enzymatic determination of total serum cholesterol. Clinical Chemistry, 20: 470-475.
American diabetes association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33: S62-S69.
Anderson, L. A., McTernan, P. G., Harte, A. L., Barnett, A. H. and Kumar, S. (2002). The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes, Obesity and Metabolism, 4: 209-213.
Arulmozhi, D. K., Veeranjaneyulu, A. and Bodhankar, S. L. (2004). Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: A glance. Indian Journal of Pharmacology, 36: 217-221.
Assmann, G., Schriewer, H., Schmitz, G. and Hägele, E. O. (1983). Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clinical Chemistry, 29: 2026-2030.
Association of Official Analytical Chemists (2006). Moisture in meat (950.46). Available at: http://www.aoac.org/oma_revision/toc.htm. Accessed Aug 9, 2014.
Baron, A. D., Laakso, M., Brechtel, G. and Edelman, S. V. (1991). Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. The Journal of Clinical Investigation, 87: 1186-1194.
Bartels, H., Bohmer, M. and Heierli, C. (1972). Serum creatinine determination without protein precipitation. Clinica Chemica Acta, 37: 193-197.
Berger, A., Rein, D., Kratky, E., Monnard, I., Hajjaj, H., Meirim, I., Piguet-Welsch, C., Hauser, J., Mace, K. and Niederberger, P. (2004). Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipid in Health and Disease, 3: 2-13.
Berger, J. J. and Barnard, R. J. (1999). Effect of diet on fat cell size and hormone-sensitive lipase activity. Journal of Applied Physiology, 87: 227-232.
Bergö, M., Olivecrona, G. and Olivecrona, T. (1996). Forms of lipoprotein lipase in rat tissues: In adipose tissue the proportion of inactive lipase increases on fasting. Biochemical Journal, 313: 893-898.
Bieger, W. P., Michel, G., Barwich, D., Biehl, K. and Wirth, A. (1984). Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism, 33: 982-978.
Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L. (2007). Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review, 13: 265-301.
Boren, J., Taskinen, M. R. and Adiels, M. (2012). Kinetic studies to investigate lipoprotein metabolism. Journal of Intern Med, 271: 166-173.
Brown, M. S. and Goldstein, J. L. (1975). A receptor-mediated pathway for cholesterol homeostasis. Science, 232: 34-47.
Bucolo, G. and David, H. (1973). Quantitative determination of serum triglycerides by the use of enzymes. Clinical Chemistry, 19: 476-482.
Butte, N. F. (2000). Cararbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. The American Journal of Clinical Nutrition, 71: 1256S-1261S.
Cai, X. L., Wang, F. and Ji, L. N. (2006). Risk factors of diabetic retinopathy in type 2 diabetic patients. Chinese Medical Journal, 119: 822-826.
Cao, L. Z. and Lin, Z. B. (2002). Regulation on maturation and function on dentritic cells by Ganoderma lucidum polysaccharides. Immunology Lettrts, 83: 163-169.
Cao, L. Z. and Lin, Z. B. (2006). Ganoderma lucidum polysaccharides peptide inhibitsthe growth of vascular endothelial cell and the induction of VEGF in human lungcancer cell. Life Science Journal, 78: 1457-1463.
Carlson, S. E. and Goldfarb, S. (1977). A sensitive enzymatic method for the determination of free and esterified tissue cholesterol. Clinica Chimica Acta, 79: 575-582.
Carmen, G. Y. and Victor, S. M. (2006). Signalling mecchanisms regulating lipolysis. Cell Signalling, 18: 401-408.
Carruthers, M., Trinick, T. R., Jankowska, E., Traish, A. M. (2008). Are the adverse effects of glitazones linked to induced testosterone deficiency? Cardiovasc Diabetol, 7: 30-36.
Catena, C., Giacchetti, G., Novello, M., Colussi, G., Cavarape, A. and Sechi L. A. (2003). Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. American Journal of Hypertension, 16: 973-978.
Chiang, J. Y. L. (2009). Bile acids: regulation of synthesis. Journal of Lipid Research, 50: 1955-1966.
Chang, M. Y., Tsai, G. J. and Houng, J. Y. (2006). Optimization of the medium composition for the submerged culture of Ganoderma lucidum by Taguchi array design and steepest ascent method. Enzyme and Microbial Technology, 38: 407-414.
Chen, Y. D., Risser, T. R., Cully, M. and Reaven, G. M. (1979). Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes, 28:893-898.
Clore, J. N., Stillman, J. and Sugerman H. (2000). Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes, 49: 969-974.
Dahlqvist, A. (1968). Assay of intestinal disaccharidases. Analytical Biochemistry, 22: 99-107.
Darlington, G. J., Ross, S. E., MacDougald, O. A. (1998). The role of C/EBP genes in adipocyte differentiation. J Biol Chem, 273: 30057-30060.
Dyer, J., Scott, D., Freeman, T. C., Wright, E. M. and Shirazi-Beechey, S. P. (1993). Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance. Biochemical Journal, 291: 435-440.
Elsner, M., Guldbakke, B., Tiedge, M., Munday, R. and Lenzen, S. (2000). Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia, 43: 1528-1533.
Erickson, R. H., Zakim, D. and Vessey, D. A. (1978). Preparation and properties of a phosphorlipid-free from of microsomal UDP-glucuronyltransferase. Biochemistry, 17: 3706-3711.
Erkel, E. I. (2009). Yield performance of Ganoderma lucidum (Fr.) Karst cultivation on substrates containing different protein and carbohydrate sources. African Journal of Agricultural Research, 4: 1331-1333.
Fang, Q. H. and Zhong, J. J. (2002). Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable metabolites-ganoderic acid and polysaccharide. Biochemical Engineering Journal, 10: 61-65.
Fisher, R. M., Coopack, S. W., Humphreys, S. M., Gibbons, G. F. and Frayn, K. N. (1995). Human triacyglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clinica Chimica Acta, 236: 7-17.
Folch, J., Less, M. and Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipids from animal tissue. The Journal of Biological Chemistry, 233: 497-509.
Foster, K. J., Alberti, K. G., Hinks, L., Lloyd, B., Postie, A., Smythe, P., Turnell, D. C. and Waiton, R. (1978). Blood intermediary metabolite and insulin concentrations after an overnight fast: references for adults and interrelations. Clinical Chemistry, 24: 1568-1572.
Fungwe, T. V., Cagen, L. M., Wilcox, H. G. and Heimberg, M. (1992). Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol. Journal of Lipid Research, 33: 179-191.
Gaskin, R. S., Estwick, D. and Peddi, R. (2001). G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus. Ethnicity and Disease, 11: 749-754.
Golay, A., Swislocki, A. L., Chen, Y. D. and Reaven, G. M. (1987). Relationship between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism, 36: 692-696.
Gómez-Valadés, A. G., Vidal-Alabró, A., Molas, M., Boada, J., Bermùdez, J., Bartrons R. and Perales, J. C. (2006). Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenelpyruvate carboxykinase (GTP) with RNAi. Molecular Therapy, 13: 401-410.
Gurung, O. K., Budathoki, U. and Parajuli, G. (2012). Effect of different substrates on the production of Ganoderma lucidum (Curt.:Fr) Karst. Our Nature, 10: 191-198.
Habijanic, J., Berovic, M., Wraber, B., Hodzar, D. and Boh, B. (2001). Immunostimulatory effects of fungal polysaccharides from Ganoderma lucidum submerged biomass cultivation. Food Technology and Biotechnology, 39: 327-331.
Hanley, J. G. A., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino Jr, R. B., Kempf, J., Zinman, B. and Haffner, S. M. (2004). Elecations in markers of liver injury amd risk of type 2 diabetes. Diabetes, 53: 2623-2632.
Hanson, R. W. and Reshef, L. (1997). Regulation of phosphoenolpyruvate carboxykinase (GTP) gene. Annual Reviews of Biochemistry, 66: 581-611.
Hassan, Z. M., Hosseini, A. Z., Raabe, S. Z. T., Mojadadi, M. S. and Shahrokhi, S. (2007). The immunomedulatory effect of Gandoerma lucidum polysachharide extract on BALB/c peritoneal macrophage function. Scientific Journal of Kurdistan University of Medical Sciences, 12: 10-17.
Holm, C. (2003). Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochemistry Society Transactions, 31: 1120-1124.
Horton, J. D., Goldstein, J. L. and Brown, M. S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, The Journal of Clinical Investigation, 109: 1125-1131.
Hsieh, C. and Yang, F. C. (2004). Reusing soy residue for the solid-state fermentation of Ganoderma lucidum. Phytotherapy Research, 4: 173-176.
Hu, M., Guan, D., Li, C. and Dai, G. (1998). Report on a first trial that cancer mice’s life was prolonged by crude extract from mycelium of Korea Ganoderma. Nanjing International Symposium on Science and Cultivation of Mushrooms. Nanjing, China.
James, D., Wolosin, M. D., Steven, V. and Edelman, M. D. (2000). Diabetes and the gastrointestinal tract. Clinical Diabetes, 18.
Jeppesen, J., Chen, Y. I., Zhou, M. Y., Schaaf, P., Coulston, A. and Reaven, G. M. (1995). Postprandial triglyceride and retinyl ester responses to oral fat: Effects of fructose. The American Journal of Clinical Nutrition, 61: 787-791.
Jia, J., Zhang, X., Hu, Y. S., Wu, Y., Wang, Q. Z., Li, N. N., Guo, Q. C. and Dong, X. C. (2009). Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chemistry, 115: 32-36.
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D. H., Gersch, M. S., Benner, S. and Sánchez-Lozada, L. G. (2007). Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. The Americam Journal of Clinical Nutrition, 86: 899-906.
Jung, K. H., Ha, E., Kim, M. J., Uhm, Y. K., Kim, H. K., Hong, S. J., Chung, J. H. and Yim, S. V. (2006). Ganoderma lucidum extract stimulates glucose uptake in L6 rat skeletal muscle cells. Acta Biochemica Polonica, 53: 597-601.
Kabir, Y., Kimura, S. and Tamura, T. (1988). Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). Journal of Nutritional Science and Vitaminology, 34: 433-438.
Kazuo, S. and Shigetoshi, S. (1999). Small-scale solid-state fermentations. Manual of Industrial Microbiology and Biotechnology, 2: 61-63.
Keith, G. T., Vivian, F., Anthony, D. and Meng, H. T. (2007). Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care, 30: 734-743.
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B. and Wahli, W. (2000). Characterization of the fasting induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. The Journal of Biological Chemistry, 275: 28488-28493.
Ko, H. H., Hung, C. F., Wang, J. P. and Lin, C. N. (2008). Anti-inflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry, 69: 234-239.
Komoda, Y., Shimizu, M., Sonoda, Y. and Sato, Y. (1989). Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chemical and Pharmaceutical Bulletin, 37: 531-533.
Korner, J., Savontaus, E., Chua, S. C., Leibel, R. L. and Wardlaw, S. L. (2001). Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus. Journal of Neuroendocrinology, 13: 959-966.
Laurent, C., Patrice, T., Fabienne, N., Stephanie, Z., Alain, M., Eric, B. and Chapman, M. J. (2002). LDL particle subclasses in hypercholesteroliemia: Molecular determinants of reduced lipid hydroperoxide stability. Journal of Lipid Research, 43: 453-462.
Li, D., Guo, S. X., Lin, S. Q. and Lin, Z. B. (2006). Effect of polyszccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. Journal of Asian Natural Products Research, 8: 705-711.
Li, Y. Q., Fang, L. and Zhang, K. C. (2007). Structure and bioactivities of galactose rich extracellular polysaccharide from subemergedly cultured Ganoderma lucidum. Carbohydrate Polymers, 68: 323-328.
Lichtenstein, L., Berbée, J. F., van Dijk, S. J., van Dijk, K. W., Bensadoun, A., Kema, I. P., Voshol, P. J., Müller, M., Rensen, P. C. and Kersten, S. (2007). Angptl 4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HSL-dependent hepatic cholesterol uptake. Arteriosclerosis, Thrombosis, and Vascular Biology, 27: 2420-2427.
Lin, E. C. K., Fernandez, M. L. and Mcnamara, D. J. (1992). Dietary fat type and cholesterol quantity interact to affect cholesterol metabolism in guinea pigs. Journal of Nutrition, 122: 2019-2029.
Liu, W., Wang, H., Pang, X., Yao, W. and Gao, X. (2010). Characterization and antioxidant activity of two low-molecular-weight polysaccharides purified from the fruiting bodies of Ganoderma lucidum. International Journal of Biological Macromolecules, 46: 451-457.
Liu, G. Q., Wang, X. L., Han, W. J. and Lin, Q. L. (2012). Improving the fermentation production of the individual key triterpene ganoderic acid me by the medicine fungus Ganoderma lucidum in submerged culture. Molecules, 17: 12575-12586.
Marshall, E. K. (1913). A new method for the determination of urea in blood. The Journal of Biological Chemistry, 15: 487-494.
Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys, D., Novelli, M. and Ribes, G. (1998). Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47: 224-229.
Meng, G., Zhu, H., Yang, S., Wu, F. Zheng, H., Chen, E. and Xu, J. (2011). Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end production and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohydrate Polymers, 84: 180-185.
Mihara, C. B., Michael, J. T. and Samir, M. (2010). Diabetes and chronic liver disease: etiology and pitfalls in monitoring. Clinical Diabetes, 28: 139-144.
Mihara, M. and Uchiyama, M. (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry, 86: 271-278.
Miholic, J., Ørskov, C., Holst, J. J. Kotzerke, J. and Meyer, H. J. (1991). Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Digestive Diseases and Sciences, 36: 1361-1370.
Mohaammed, A., Adelaiye, A. B., Abubakar, M. S. and Abdurahman, E. M. (2007). Effects of aqueous extract of Ganoderma lucidum on blood glucose levels of normoglycemic and alloxan-induced diabetic wistar rats. Journal of Medicine Plants Research, 1: 034-037.
Morigiwa, A., Kitabatake, K., Fujimoto, Y. and Ikekawa, N. (1986). Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chemical and Pharmaceutical Bulletin, 34: 3025-3028.
Morimoto, C., Kameda, K., Tsujita, T. and Okuda, H. (2001) Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. The Journal of Lipid Research, 42: 120-127.
Murase, T., Yamada, N. and Matsuzaki, F. (1981). The in vitro effect of growth hormone on adipose tissue lipoprotein lipase in rats. Life Sciences, 28: 199-201.
Murat, J. C. and Serfaty, A. (1974). Simple enzymatic determination of polysaccharide (glycogen) content of animal tissue. Clinical Chemistry, 20: 1576-1577.
Musi, N., Hayashi, T., Fujii, N., Hirshman, M. F., Witters, L. A. and Goodyear, L. J. (2001). AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. American Journal of Physiology: Endocrinology and Metabolism, 280: E677-E684.
Nagayama, F., Ohshima, H. and Umezawa, K. (1972). Distribution of glucose-6-phosphate metabolizing enzyme in fish. Bulletin of the Japanese Society of Scientific Fisheries, 38: 589-593.
Nataha, A. (2013). Ganoderma lucidum: A potent medicinal mushroom with numerous health benefits. Pharmaceutica Analytica Acta, 4: e159-e162.
Nepokroeff, C. M., Lakshmanan, M. R. and Porter, J. W. (1975). Fatty-acid synthase from rat liver. Methods in Enzymology, 35: 37-44.
Nukatsuka, M., Yoshimura, Y., Nishida, M. and Kawada, J. (1990). Allopurinol protects pancreatic beta cells from the cytotoxic effect of streptozotocin: In vitro study. Journal of Pharmacobio-Dynamics, 13: 259-262.
Numa, S., Ringelmann, E. and Lynen, F. (1965). On inhibition of acetyl-CoA-carboxylase by fatty acid-coenzyme A compounds. Biochemische Zeitschrift, 343: 243-257.
O’Dea, K (1984). Marked improvement in carbohydrate and lipid metabolism in diabetic australian aborigines after temporary reversion to traditional lifestyle. Diabetes, 33: 596-603.
Olsson, R. and Carlsson, P. O. (2005). Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia, 48: 469-476.
Oluba, O. M., Olusola, A. O., Eidangbe, G. O., Babatola, L. J. and Onyeneke, E. C. (2012). Modulation of lipoprotein cholesterol levels in Plasmodium berghei malarial infection by crude aqueous extract of Ganoderma lucidum. Cholesterol.
Pan, D., Zhang, D., Wu, J., Chen, C., Xu, Z., Yang, H. and Zhou, P. (2014). A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorate diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice. Food and Chemical Toxicology, 63: 111-118.
Pan, D., Zhang, D., Wu, J., Chen, C., Xu, Z., Yang, H. and Zhou, P. (2013). Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism. PLoS ONE, 8: e68332-e6841.
Peksen, A. and Yakupoglu, G. (2009). Tea waste as a supplement for the cultivation of Ganoderma lucidum. World Journal of microbiological Biotechnology, 25: 611-618.
Peng, Y., Zhang, L., Zeng, F. and Kennedy, J. F. (2005). Structure and antitumor activities of the water-soluble polysaccharides from Ganoderma tsugae mycelium. Carbohydrate Polymers, 59: 385-392.
Prasad, S. and Shinha, A. K. (2010). Free radical activity in hypertensive type 2 diabetic patients. International Journal of Diabetes Mellitus, 2: 141-143.
Quinn, DM., Shirai, K., Jackson, RL. and Harmony, JA. (1982) Lipoprotein lipase catalyzed hydrolysis of water-soluble p-nitrophenyl esters. Inhibition by apolipoprotein C-Ⅱ. Biochemistry, 21: 6872-6879.
Ren, Z. and Niu, W. X. (2006). Basic physiology and function of the intestinal glucose transporter: GLUT5 and SGLT1. International Journal of Pathology and Clinical Medicine, 26: 0536-0541.
Rupert, G. C. Y. and Wolfe, M. M. (2000). GIF biolgy and fat metabolism. Life Sciences, 66: 91-103.
Rydtren, T. and Sandler, S. (2002). Efficacy of 1,400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. European Journal of Endocrinology, 147: 543-551.
Saslaw, L. D., Anderson, H. J. and Waravdekar, V. S. (1963). Ultra-violet photolysis of unsaturated fatty acids in relation to the thiobarbituric acid test. Nature, 200: 1098-1099.
Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A, M., Heyman, R, A., Briggs, M., Deeb, S., Staels, B. and Auwerx, J. (1996). PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. The EMBO Journal, 15: 5336-5348.
Sessions, V. A. and Salter, A. M. (1994). The effects of different dietary fats and cholesterol on serum lipoprotein concentration in hamsters. Biochimica et Biophysica Acta, 1211: 207-214.
Seto, S. W., Lam, T. Y., Tam, H. L., Au, A. L., Chan, S. W., Wu, J. H., Yu, P. H., Leung, G. P., Ngai, S. M., Yeung, J. H., Leung, P. S., Lee, S. M. and Kwan, Y. W. (2009). Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine, 16: 426-436.
Shafrir, E., Ziv, E. and Mosthaf, L. (1999). Nutritionally induced insulin resistance and receptor defect leading cell failure in animal models. Annals of the New York Academy of Sciences, 892: 223-246.
Shanik, M. H., Xu, Y., Skrha, J., Dankner, R., Zick, Y. and Roth J. (2008). Insulin Resistance and Hyperinsulinemia, is hyperinsulinemia the cart or the horse? Diabetes Care, 31: S262-S268.
Shao, J., Qiao, L., Janssen, R. C., Pagliassotti, M. and Friedman, J. E. (2005). Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabete, 54: 976-984.
Shiao, M. S. (2003). Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chemical Record, 3: 172-180.
Shieh, Y. H., Liu, C. F., Huang, Y. K., Yang, J. Y., Wu, I. L., Lin, C. H. and Lin, S. C. (2001). Evaluation of the hepatic and renal-protective effects of Ganoderma lucidum in mice. The American Journal of Chinese Medicine, 29: 501-507.
Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S. and Goldstein, J. S. (1999). Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proceedings of the National Academy of Sciences, 96: 13656-12661.
Shirai, K. and Jackson, RL. (1982) Lipoprotein lipase-catalyzed hydrolysis of p-nitrophenyl butyrate. Interfacial activation by phospholipid vesicles. The Journal of Biological Chemistry, 257: 1253-1258.
Solano, M. P. and Goldberg, R. B. (2006). Lipid management in type 2 diabetes. Clinical Diabetes, 24: 27-32.
Song, Y., Manson, J. E., Tinker, L., Howard, B. V., Kuller, L. H., Nathan, L., Rifal, N. and Liu, S. (2007). Insulin sensitivity and insulin secretion determined by homeostasis model assessment (HOMA) and risk of diabetes in a nultiethnic cohort of women: the women’s health initiative observational study. Diabetes Care, 30: 1747-1752.
Srinivasan, K. and Ramarao, P. (2007). Animal models in type 2 diabetes research: An overview. Indian Journal of Medical Research, 125: 451-472.
Stryer, L. (1988). Biochemistry, 3rd edn. Academic press, U.S. 390.
Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A. and Feinglos, M. N. (1988). Diet-induced type 2 diabetes in C57BL/6J mice. Diabetes, 37: 1163-1167.
Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research, 50: 537-546.
Tang, Y. J. and Zhong, J. J. (2002). Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid. Enzyme and Microbial Technology, 31: 20-28.
Teng, B. S., Wang, C. D., Zhang, D., Wu, J. S., Pan, D., Pan, L. F., Yang, H. J. and Zhou, P. (2012). Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. European Review for Medical and Pharmacological Sclences, 16: 166-175.
Thyagarajan, A., Jedinak, A., Nguyen, H., Terry, C., Baldridge, L. A. Jiang, J. and Sliva, D. (2010). Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutrition and Cancer, 62: 630-640.
Thyagarajan-Sahu, A., Lane, B. and Sliva, D. (2011). ReishiMax mushroom based dietary supplement inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complementary and Alternative Medicine, 11: 74-88.
Tie, L., Yang, H. Q., An, Y., Liu, S. Q., Han, J., Xu, Y., Hu, M., Li, W. D., Chen, A. F., Lin, Z. B. and Li, X. J. (2012). Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cellular Physiology and Biochemistry, 29: 583-594.
Tietz, A, D., Rinker, N, W. and Shaw, L, M. (1980). International Federation of Clinical Chemistry, scientific committee. Journal of Clinical Chemistry and Clinical Biochemistry, 18: 521-534.
Trayhurn, P. and Beattie, J. H. (2001). Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Priceeding of the Nutrition Society, 60: 329-339.
Trinder, P. (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen receptor. Annals of Clinical Biochemistry, 6: 24-27.
Turk, J., Corbett, J. A., Ramanadham, S., Bohrer, A. and McDaniel, M. L. (1993). Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochemical and Biophysical Research Communications, 197: 1458-1464.
Vilsboll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courrêges, J. P., Verhoeven, R., Bugãnovã, I. and Madsbad, S. (2007). Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care, 30: 1608-1610.
Wagner, R., Mitchell, D. A., Sassaki, G. L., de Almeida Amazonas, M. A. L. and Berovic, M. (2003). Current techniques for the Cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technology and Biotechnology, 41: 371-382.
Wang, F., Zhou, Z., Ren, X., Wang, Y., Yang, R., Luo, J. and Strappe, P. (2015). Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats. Lipid in Health and Disease, 14: 49-57.
Wang, S. Y., Hsu, M. L., Hsu, H. C., Tzeng, C. H., Lee, S. S., Shiao, M. S. and Ho, C. K. (1997). The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International Journal of Cancer, 70: 699-705.
Wickelgren, I. (1988). Obesity how big problem. Science, 280: 1364-1367.
Wright, S. W., Carlo, A. A., Danley, D. E., Hageman, D. L., Karam, G. A., Mansour, M. N., McClure, L. D., Pandit, J., Schulte, G. K., Treadway, J. L., Wang, I. K. and Bauer, P. H. (2003). 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site. Bioorganic and Medicinal Chemistry Letters, 13: 2055-2058.
Wroblewski, F. (1956). The significance of alterations in serum enzymes in the differential diagnosis of jaundice. AMA Internal Medicine, 100: 635-641.
Xi, X., Han, J. and Zhang, J. Z. (2001). Stimulation of Glucose Transport by AMP-activated Protein Kinase via Activation of p38 Mitogen-activated Protein Kinase. The Journal of Biological Chemistry, 276: 41029-41034.
Xiao, C., Wu, Q. P., Cai, W., Tan, J. B., Yang, X. B. and Zhang, J. M. (2012). Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Archives of Pharmacal Research, 35: 1793-1801.
Xie, S., Liao, W., Yao, Z and Wang, Z. (2008). Related gene expressions in anti-keratinocyte aging induced by Ganoderma lucidum polysaccharides. Journal of Meducal Colleges of PLA, 23: 167-175.
Yagi, K. (1976). A simple fluorometric assay for lipoperoxide in blood plasma. Biochemical medicine, 15: 212-216.
Yang, X. J., Liu, J., Ye, L. B., Yang, F., Ye, L., Gao, J. R. and Wu, Z. H. (2006). In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World Journal of Gastroenterology, 12: 1379-1385.
Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y., Soukas, A., Friedman, J. M., Holmes, W. E. and Spiegelman, B. M. (2000). Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Molecular and Cellular Biology, 20: 5343-5349.
Zhang, G. L., Wang, Y. H., Ni, W., Teng, H. L. and Lin, Z. B. (2002). Hepatoptective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology, 8: 728-733.
Zhang, H. N. and Lin, Z. B. (2004). Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacologica Sinica, 25: 191-195.
Zhang, K., Li, P. and Huopo, X. R. (1998). Studies on the bioactive compounds produced by submerged fermentation of Ganoderma lucidum-polysaccharide. Process Biochemistry, 21: 40-47.
Zhou, X., lin, Y., Yin, J., Zhao, X., Sun, X. and Tang, K. (2007). Ganoderma taceace: natural products and their related pharmacological functions. Am. Chinese Medical Association, 35: 559-574.
Zhou, Y. T., Shimabukuro, M., Lee, Y., Koyama, K., Higa, M., Ferguson, T. and Unger, R. H. (1998). Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogensis of lipotoxic diabetes. Diabetes, 47: 1904-1908.
Zierath, J. R., Krook, A. and Wallberg-Henriksson, H. (2000). Insulin action and insulin resistance in human skeletal muscle. Diabetologia, 43: 821-835.